Introduction
Paracoccidioidomycosis (PCM), caused by the thermally dimorphic fungus Paracoccidioides brasiliensis , is the most prevalent human systemic mycosis in Latin America. It is endemic in Brazil, Argentina, Venezuela, and Colombia. The infection begins after inhalation of airborne conidia which convert to yeast cells in the lungs [1] . When the yeast cells are not eliminated, PCM may develop into multiple pathogen-associated molecular patterns (PAMPs). The most physiologically important IL-12 target cells are T lymphocytes, in which IL-12 induces proliferation and differentiation to cells that produce type-1 cytokines, particularly IFN-γ. IL-12 is a highly effi cient IFN-γ inducer, acting at low concentrations, and it also acts in synergy with other activating stimuli (reviewed by [12] ). This sequence of events initiates and amplifi es the innate and adaptive Th1-cell immunity.
We have previously shown that ArtinM, a D-mannosebinding lectin from jackfruit ( Artocarpus integrifolia ), induces IL-12 production via recognition of TLR2 glycans on either macrophages or dendritic cells, thereby switching the cytokine profi le in mice from Th2 (IL-4) to Th1 (IFN-γ) [13, 14] . As a consequence, ArtinM induces a protective Th1-type response against intracellular pathogens, such as Leishmania [14, 15] and P. brasiliensis [13] . In the case of Leishmania infection, the effect of ArtinM was evaluated when it was prophylactically administered, whereas in the study of P. brasiliensis infection, ArtinM was therapeutically employed. In the present work, we have investigated the effect exerted on experimental PCM by native and recombinant ArtinM when they are administered in a prophylactic regimen.
Materials and methods

Mice
The animals used for this study were 6-8-week-old male BALB/c mice. They were bred and maintained under standard conditions in the animal house of the Ribeirão Preto School of Medicine, São Paulo University, Ribeirão Preto, SP, Brazil. Each experimental group consisted of fi ve mice and the assays were done in duplicates. All animal experiments were performed in accordance with protocols approved by the Institutional Animal Care and Use Committee.
Fungal isolate
The virulent P. brasiliensis isolate (Pb18) used in this study was maintained on Fava-Netto's semisolid medium at 36°C for 7 days. To maintain virulence, consecutive passages in mice were accomplished by intravenous infection, and the yeast recovered from the lung tissue reinoculated on the indicated culture medium. The viability of the yeast cells, determined by fl uorescein diacetate and ethidium bromide staining [16] , was always greater than 90%.
ArtinM affi nity-purifi cation
Native ArtinM from jackfruit seeds ( A. integrifolia L.f.) was purifi ed as previously described [17] . The lectin recombinant form (rArtinM) was expressed in Escherichia coli BL21 transformed with pExp-ArtinM and purifi ed as previously reported [18] . ArtinM preparations (from plant or recombinant) contained less than 0.05 ng/ml of bacterial endotoxin, as determined by the Limulus amoebocyte lysate assay (Sigma Chemical Co., St. Louis, USA).
ArtinM administration and intravenous infection of mice
Mice divided into 4 groups of fi ve mice each were injected subcutaneously (s.c.) with 0.5 μg ArtinM in 50 μL PBS. The treatments varied according to the number of ArtinM injections (1-3 doses) and time intervals between each ArtinM injection (Table 1) . To determine the most effective regimen of ArtinM administration, all groups were challenged by intravenous (i.v.) injection into the lateral tail vein of 0.1 ml of the inoculum (1 ϫ 10 6 P. brasiliensis yeast cells). The uninfected control mice were inoculated with 0.1 mL of sterile pyrogen-free PBS. On the basis of the results provided by these screening procedures, the protocol in which the mice were injected with two s.c. doses of ArtinM or rArtinM on days 10 and 3 before infection was employed in the subsequent experiments. The control mice, which were submitted to a similar regimen of injections, received PBS (50 μg) instead of ArtinM. The course of infection was evaluated on days 14 and 30 after exposure to the fungus.
Quantifi cation of colony-forming units (CFU)
The mice were killed by exsanguination on days 14 and 30 postinfection and examined for fungal burdens in the lungs, liver and spleen, as previously described [19] . Briefl y, one lung of each animal was aseptically removed and disrupted in 1 ml PBS containing 1.6 mM phenylmethylsulfonyl fl uoride (PMSF, Sigma Chemical Co.), using a tissue homogenizer (Ultra-Turrax T25 Basic, IKA Works, Inc., Wilmington, USA). The number of viable P. brasiliensis organisms was determined by plating crude and serially diluted homogenates onto brain heart infusion agar (BHI; Oxoid Ltd., Hampshire, UK), supplemented with 4% (v/v) heat-inactivated fetal calf serum (FCS; Invitrogen, analysis of variance (ANOVA) followed by Bonferroni post test. Differences that provided P Ͻ 0.05 were considered to be statistically signifi cant. All experiments were performed at least three times.
Results
Screening the regimen of ArtinM administration
In order to evaluate whether the prophylactic administration of ArtinM is able to interfere in PCM in the murine model and to determine the most effective regimens of ArtinM administration in conferring protection against the disease, groups of BALB/c mice were submitted to treatments that varied according to the number and time intervals of injections (see Table 1 ) and then i.v. inoculated with P. brasiliensis yeasts. Histopathology examination of the lungs showed ( Fig. 1 ) that mice from group 2, i.e., those injected with ArtinM on days 10 and 3 before infection, presented the most preserved organ architecture, a mild leukocyte infi ltration, and absence of yeast cells (Fig.1D ). In contrast, severe lesions were observed in the lungs of the untreated mice (control group, Fig. 1B ). Intermediate severity of lesions was observed in the lungs of mice from the screened groups 1 (Fig. 1C) , 3 ( Fig. 1) , and 4 ( Fig. 1F ). Morphometric analysis revealed that granuloma density was signifi cantly lower in the lungs of mice from groups 2 (0.66 granuloma/mm 2 ) and 4 (1.5 granuloma/ mm 2 ) ( Fig. 2A) , that received ArtinM on days 10 and 3 before infection, and only on day 3 before infection, respectively. On the other hand, the lung of mice treated according to protocols 1 and 3 had less than 3 granuloma/ mm 2 , which was quite different from the almost 4 granuloma/mm 2 counted in the pulmonary tissue of mice from the untreated control group. The outstanding results of group 2, as judged from histopathology criteria, were reinforced by the results of the fungal burden analysis, performed by CFU recovery from tissue. The pulmonary fungal burden was 95% reduced in group 2, compared with the control group (Fig.  2B ). Intriguingly, group 3, comprised of mice treated only on day 10 before infection, had a larger recovery of CFU than the control group. Since ArtinM administration protocol 2 was unequivocally the most effi cient, it was used in all subsequent experiments.
Prophylaxis with ArtinM protects mice against P. brasiliensis infection
The effects of ArtinM and rArtinM administration using protocol 2 were investigated in detail. Pulmonary histopathology in the untreated animals on day 30 after i.v. infection showed multiple sites of focal and confl uent epithelioid granulomas with lymphomonocytic halos circumscribing Camarillo, CA, USA) and incubated at 36°C for 15 days. The lower limit of detection was 10 CFU. The number of P. brasiliensis colonies per gram of organ was given as the mean and standard deviation (SD). The lung homogenate supernatants were also separated from cell debris by centrifugation at 2,000 g for 15 min, and stored at −20°C until ELISA-based cytokine and nitric oxide (NO) measurements were performed.
Histopathology
On day 30 postinfection, the lungs were fi xed in 10% neutral buffered formalin for 24 h and embedded in paraffi n. Tissue sections (5 μm) were stained with hematoxylin and eosin (H&E) and examined by light microscopy with a Axiophot photomicroscope (Carl Zeiss, Jena, Germany) coupled with a JVC TK-1270 camera (Victor Company of Japan Ltd, Tokyo, Japan). The area of individual granulomas, as well as the total area of the lung sections and the area taken by granulomas per slide, was measured by computer-aided image analysis (ImageJ 1.37v, National Institutes of Health, Bethesda, USA).
ELISA-based cytokine detection assay
The levels of IL-12p70, IL-4, IL-10, IFN-γ, and TNF-α in the supernatants of the lung homogenate were measured by capture enzyme-linked immunosorbent assay (ELISA) with antibody pairs purchased from Pharmingen (San Diego, USA). The ELISA procedure was performed according to the manufacturer's protocol. The cytokine concentrations were determined with reference to a standard curve for serial two fold dilutions of the murine recombinant cytokines.
NO production
NO production was quantifi ed by the standard Griess reaction. Briefl y, 50 μl of supernatants from the lung homogenates were incubated with an equal volume of Griess reagent (1% sulfanilamide, 0.1% naphthylene diamine dihydrochloride, and 2.5% H 3 PO 4 ) at room temperature for 10 min. The absorbance was measured at 550 nm in the Microplate Scanning Spectrophotometer (Power Wavex -BIO-TEK Instruments, Inc., Winooski, USA). The conversion of absorbance into micromolar concentrations of NO was deduced from a standard curve using a known concentration of NaNO 2 .
Statistical analysis
Statistical determinations of the difference between means of experimental groups were performed using one-way Fig.1 Lung histopathology of infected mice submitted to the screening protocols of ArtinM prophylactic administration. Mice were i.v. infected with 10 6 P. brasiliensis yeast cells and analysis was performed at day 30 after infection. The panels show representative lung sections from mice that were not infected (A); that were infected and not treated (B); that were infected and prophylatically treated according to protocol 1 (C), protocol 2 (D), protocol 3 (E), or protocol 4 (F). The most preserved lung structure is observed in the mice treated according to protocol 2 (D), whereas the other groups showed variable degrees of parenchyma lesions. The lung sections were H&E stained. Scale bars indicate 200 μm.
yeast cells (Fig. 3A) . In addition, multiple and confl uent typical epithelioid granulomas were observed in the liver and spleen from all mice of this control group (data not shown). In contrast, in the lungs of mice prophylactically injected with ArtinM or rArtinM (Fig. 3B & C) , no granulomas or yeast cells were seen, and the bronchoalveolar architecture was well preserved. There were no granulomas in the liver or spleen at any of the analyzed times (data not shown). The CFUs of P. brasiliensis yeast cells recovered from the lungs of at 30 days postinfection were examined. The CFU recovered from the lungs of the mice prophylactically treated (Fig. 3D) with either ArtinM or rArtinM was 91% or 81% lower than the number recovered from the non-treated control mice, respectively. These observations were reinforced by the fact that on day 30 postinfection no yeast cells were recovered from the liver or spleen of any ArtinM-treated mice, while the control mice still presented infectious burdens at this time (data not shown). The CFU data concur with the histopathology results and provide strong evidence that administration of both ArtinM and rArtinM according to protocol 2 exerts a protective effect against P. brasiliensis infection.
Production of pro-and anti-infl ammatory cytokines and NO in P. brasiliensis infected-mice
Since the native and recombinant ArtinM treatment was effective in protecting mice against P. brasiliensis infection, the question of whether an adequate milieu of pulmonary cytokines correlated with the advantageous effect of lectin administration was addressed. Analysis of the production of pro-and anti-infl ammatory cytokines in the supernatants of lung homogenates from the P. brasiliensisinfected mice treated with ArtinM or rArtinM showed that on day 14 postinfection, the levels of IL-12p70, IFN-γ, IL-10, and IL-4 were not signifi cantly different from those of the control group (Fig. 4, A, C-E) . Only the TNF-α levels were found to be higher in the lung of ArtinM treated groups (Fig. 4B) . On day 30 postinfection, higher concentrations of TNF-α (Fig 4B) and IL-12 (Fig. 4A) were detected among the ArtinM-treated mice as compared with the controls. The differences between treated and untreated mice were still more evident when the time course of cytokines production was analyzed. A signifi cantly lower (P Ͻ 0.05) amount of IL-12p70 was produced by the control mice on day 30 postinfection than on day 14 postinfection, whereas in ArtinM-treated mice the amount of IL-12p70 was stable or augmented during the course of infection (Fig. 4A) . The levels of IFN-γ (Fig. 4C ) and IL-4 (Fig. 4D) were stable in the treated groups, and variable in the untreated group. Lower IFN-γ and higher of IL-4 levels were detected on day 30 compared with these same levels on day 14 postinfection. The IL-10 levels increased in all groups from day 14 to 30 postinfection (Fig. 4E) . Assays to evaluate nitrite production were performed in parallel with cytokine detection. Low levels of nitrite were detected on day 14 postinfection in the lungs of mice from all groups (Fig. 4F) . On the other hand, on day 30 postinfection the prophylaxis group had much higher nitrite levels than the control ( P Ͻ 0.05).
Discussion
Following the demonstration that ArtinM administration confers protection against subsequent challenge with Leishmania through induction of Th1-biased immunity, which in turn does not depend on the immunization with specifi c antigen(s) [14] , new studies concerning the applicability of this lectin as an immunomodulatory agent have been performed. ArtinM has been shown to be useful with other intracellular pathogens [13, 15] and to be effective in P. brasiliensis infection when it is therapeutically administered [13] . The current study was undertaken to investigate whether the prophylactic administration of ArtinM, in either its native or recombinant form, could also modify the course of P. brasiliensis infection. We found that protection was conferred by prophylactic administration of either form of the lectin. The Th1-prone immune response that developed exerted a direct benefi cial effect on the severity of the disease, as determined by lung histophatology and CFU counts.
Whereas mice given no lectin exhibited extensive granulomatous lesions that characterize severe PCM, the animals that received prophylaxis with ArtinM or rArtinM showed signifi cantly lower number of granulomas and decreased pulmonary fungal burden. Moreover, the lungs of only a few ArtinM-treated mice presented abnormalities, such as mild granulomatous infl ammation, which were never accompanied by the dissemination of the fungus to the liver and spleen (data not shown) as found with untreated mice. As an exception, higher numbers of CFU were recovered from the lungs of mice treated as per protocol 3 compared with untreated control mice. We cannot explain these results, especially considering that the tissue injury was not more severe in group 3 mice and a low number of granuloma/mm 2 was found in their lungs. Considering the key role exerted by cytokines [20] [21] [22] [23] [24] in the course of paracoccidioidomycosis, their concentrations in the lung homogenates obtained from the control and ArtinM-treated mice were compared. The treated group exhibited an increase in the pulmonary proinfl ammatory cytokine levels, as well as in the nitrite levels, as compared to the control group. These observations are similar to the Th1 profi le required for protection against PCM [11] and agree with our previous data concerning ArtinM therapy against PCM [13] . We have already demonstrated that the protection induced by ArtinM is attributable to the lectin interaction with TLR2 [13] . On the other hand, Loures and colleagues [25] established that TLR2 expression determines a benefi cial effect on P. brasiliensis pulmonary infection, which is due to a negative control on Th17 immunity and tissue pathology. This TLR2 activity can be related with the absence of infl ammatory injury following ArtinM administration in non-infected mice (not shown), in addition to the non-exacerbated infl ammatory response in P. brasiliensis infected mice following therapy [13] or prophylaxis with ArtinM. Such an effect of ArtinM is advantageous in comparison to the administration of exogenous IL-12 since it diminished the severity of the infection, but also induced a high infl ammatory response [20] . A complementary explanation for the ArtinM advantageous effect may be the fact that the induced high IL-12 production was balanced by the deactivating cytokine IL-10, detected in substantial concentrations. Nevertheless, IL-10 levels in the ArtinM-treated mice were signifi cantly lower than those seen in non-treated animals. This result constitutes a distinction between the prophylactic and therapeutic effects of ArtinM on PCM, i.e., the animals undergoing therapy presented IL-10 levels as high as the ones detected in non-treated mice [13] . In spite of this distinction, the effects of ArtinM were equally beneficial whether administered in a prophylactic or a therapeutic regimen. Our results indicate that both regimens of ArtinM administration generate a lung environment that effi ciently controls fungal growth and avoids systemic dissemination of the etiologic agent. In addition, as in the case of the therapeutic protocol, the prophylactic administration of ArtinM did not elicit an anti-ArtinM humoral response (data not shown).
PCM is usually fatal in the absence of specifi c treatment. Most often, treatment lasts for up to 2 years, patients experience toxic drug side effects and relapses. In addition, host immune imbalance limits the effi cacy of anti-fungal chemotherapy [26] . For these reasons, one important strategy to fi ght fungal disease is to improve the host immune reactions. Although various cytokines have proven to be benefi cial in fungal infections, the Th1/Th2-cell balance itself seems to be the ultimate target of immunotherapy [27] . The demonstration that ArtinM administration promotes high IL-12 production supports the idea of the pharmaceutical applicability of ArtinM. This is because ArtinM favors Th1 immunity and NO production, whose importance in the protection against intracellular pathogens is well established. Considering the observation that protection against P. brasiliensis was maintained for more than 4 weeks in ArtinM-treated mice, we hypothesize that the lectin effects on the innate immunity have repercussions on the adaptive response, a supposition supported by a vast literature data regarding the bridge between innate and adaptative immunity (reviewed by [28, 29] ). Consequently, the occurrence of a robust cell-mediated immunity, characteristically required to confer protection against P. brasiliensis infection, might be favored. Besides, since T cells also express TLRs, a direct interaction of ArtinM with cells of the adaptive immunity is plausible and, in this case, it could also contribute to maintaining the protection observed in the treated mice. On the basis of recent demonstrations that TLR2 controls both the expansion and function of T regulatory cells [30] and the observation that ArtinMtreated mice show high pulmonary levels of IL-10, we can also suppose that ArtinM interaction with TLR2 on cells of the innate immunity reverberates in Tregs, thus minimizing a deleterious effect eventually caused by strong and uncontrolled infl ammatory responses. This hypothesis is consistent with our fi ndings of a mild infl ammatory response in P. brasiliensis infected mice after therapy [13] or prophylaxis with ArtinM, in spite of the detection of high IL-12 and NO levels. Nonetheless, a further detailed investigation is obligatory to clarify the apparent deleterious effect exerted by ArtinM treatment. This was observed when in our initial screening of protocols for the administration of this lectin, a single dose was given to mice on day 10 before infection.
It is probable that the valuable immunomodulation provided by ArtinM is related to its pleiotropic effects. An overall study to identify the cells of the immune system that correspond to targets for ArtinM recognition and signaling is being performed in our laboratory.
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